R. Sarrami-forooshani, S. Das, F. Sabahi, A. Adeli, R. Esmaeili et al., Molecular analysis and phylogenetic characterization of HIV in Iran, Journal of Medical Virology, vol.383, issue.7, pp.853-63, 2006.
DOI : 10.1002/jmv.20634

S. Jamehdar, F. Sabahi, M. Forouzaneh, M. Haji-abdolbaghi, A. Kazemnejad et al., Application of SYBR-Green Real Time RT-PCR quantification of human immunodeficiency virus type-1 (HIV-1) and comparison with Cobas Amplicor Test, Modares Jouranl of Medical Sciences Summer, pp.43-50, 2007.

S. Jamehdar, F. Sabahi, M. Forouzandeh, H. Abdolbaghi, M. Kazemnejad et al., Evaluation of a new, highly sensitive and specific primer set for reverse-transcriptase PCR detection of HIV-1 infected patients: Comparison with standard primers, J Biol Sci. UNAIDS/ WHO, vol.7, issue.7, pp.954-962, 2007.

M. Girard, S. Osmanov, and M. Kieny, A review of vaccine research and development: The human immunodeficiency virus (HIV)???, Vaccine, vol.24, issue.19, pp.4062-81, 2006.
DOI : 10.1016/j.vaccine.2006.02.031

M. Giri, K. Ugen, and D. Weine, DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade, Clinical Microbiology Reviews, vol.17, issue.2, pp.370-89, 2004.
DOI : 10.1128/CMR.17.2.370-389.2004

S. Calarota and D. Weiner, Present status of human HIV vaccine development, AIDS, vol.17, issue.Supplement 4, pp.573-84, 2003.
DOI : 10.1097/00002030-200317004-00009

M. Estcourt, A. Mcmichael, and T. Hanak, DNA vaccines against human immunodeficiency virus type 1, Immunological Reviews, vol.162, issue.1, pp.144-55, 2004199.
DOI : 10.1016/S0022-1759(98)00004-0

C. Gómez, F. Abaitua, D. Rodríguez, and E. M. , Efficient CD8 + T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and MVA strains) immunization regime and enhancement by the cytokine IFN-?. Virus Res, pp.11-22, 2004.

R. Macgregor, J. Boyer, K. Ugen, P. Tebas, T. Higgins et al., Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results enhanced CD8 T-cell immunity and increased control of viral" blips". Vaccine, pp.2066-73, 200518.

J. Qiu, R. Song, M. Dettenhofer, C. Tian, T. August et al., Evaluation of Novel Human Immunodeficiency Virus Type 1 Gag DNA Vaccines for Protein Expression in Mammalian Cells and Induction of Immune Responses, J Virol, vol.73, pp.9145-52, 1999.

M. Sarbolouki and M. Sadeghizadeh, Dendrosomes: a novel family of vehicles for transfection and therapy, Journal of Chemical Technology & Biotechnology, vol.7, issue.10, pp.919-941, 2000.
DOI : 10.1002/1097-4660(200010)75:10<919::AID-JCTB308>3.0.CO;2-S

Y. Xiao, Y. Lu, and Y. Chen, Epitope-vaccine as a new strategy against HIV-1 mutation, Immunology Letters, vol.77, issue.1, pp.3-6, 2001.
DOI : 10.1016/S0165-2478(01)00187-0

S. Bazhan, P. Belavin, S. Seregin, N. Danilyuk, I. Babkina et al., Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens, Vaccine, vol.22, issue.13-14, pp.1672-82, 2004.
DOI : 10.1016/j.vaccine.2003.09.048

N. Balenga, F. Zahedifard, R. Weiss, M. Sarbolouki, . Thalhamer et al., Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergy, Journal of Biotechnology, vol.124, issue.3, pp.602-616, 2006.
DOI : 10.1016/j.jbiotec.2006.01.014

X. Dong, Y. Xiao, M. Dierich, and Y. Chen, N- and C-domains of HIV-1 gp41: mutation, structure and functions, Immunology Letters, vol.75, issue.3, pp.215-235, 2001.
DOI : 10.1016/S0165-2478(00)00302-3

O. Usam, P. Xiao, H. Ling, Y. Liu, T. Nakasone et al., Properties of anti-gp41 core structure antibodies, which compete with sera of HIV-1-infected patients. Microbes Infect, pp.650-657, 2005.

B. Janvier, A. Baillou, P. Archinard, M. Mounier, B. Mandrand et al., Immune Response to a Major Epitope of p24 during Infection with Human Immunodeficiency Virus Type 1 and Implications for Diagnosis and Prognosis, Antimicrobial Agents and Chemotherapy, vol.36, issue.4, pp.488-92, 1991.
DOI : 10.1128/AAC.36.4.906

H. Li, Z. Liu, J. Ding, and Y. Chen, Recombinant multi-epitope vaccine induce predefined epitope-specific antibodies against HIV-1, Immunology Letters, vol.84, issue.2, pp.153-160, 2002.
DOI : 10.1016/S0165-2478(02)00175-X

J. Megede, G. Otten, B. Doe, H. Liu, L. Leung et al., Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 Subtype B pol and gagpol DNA Vaccines, Journal of Virology, vol.77, issue.11, pp.6197-207, 2003.
DOI : 10.1128/JVI.77.11.6197-6207.2003

M. Chattergoon, V. Saulino, J. Shames, J. Stein, L. Montaner et al., Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice, Vaccine, vol.22, issue.13-14, pp.1744-50, 2004.
DOI : 10.1016/j.vaccine.2004.01.036

M. Gherardi, J. Ramirez, D. Rodríguez, J. Rodríguez, G. Sano et al., IL-12 delivery from Recombinant Vaccinia Virus Attenuates the Vector and Enhances the Cellular Immune Response Against HIV-1 Env in a Dose-Dependent Manner, J Immunol, vol.162, pp.6724-6757, 1999.

K. Heckman and R. Pease, Gene splicing and mutagenesis by PCR-driven overlap extension, Nature Protocols, vol.2, issue.4, pp.924-956, 2007.
DOI : 10.1038/nprot.2007.132

R. Horton, PCR-mediated recombination and mutagenesis, Molecular Biotechnology, vol.8, issue.2, pp.93-102, 1995.
DOI : 10.1007/BF02789105

M. Matsui, O. Moriya, and T. Akatsuka, Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid. Vaccine, pp.1629-1668, 2003.

A. Karami, M. Sarbolouki, F. Khatami, and N. Rastgoo, CPG motif as an adjuvant in immunization of a recombinant plasmid encoding hepatitis C virus core protein, Iranian J Bitotechnol, vol.3, pp.64-70, 2005.

F. Mahboudi, N. Irina, C. A. Ghadiri, A. Adeli, A. Amini-bavil-olyaee et al., A serological screening assay of human immunodeficiency virus type 1 antibodies based on recombinant protein p24???gp41 as a fusion protein expressed in Escherichia coli, Journal of Biotechnology, vol.125, issue.2, pp.295-303, 2006.
DOI : 10.1016/j.jbiotec.2006.03.021

J. Kim, L. Nottingham, D. Wilson, M. Bagarazzi, A. Tsai et al., Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes, Vaccine, vol.16, issue.19, pp.1828-1863, 1998.
DOI : 10.1016/S0264-410X(98)00177-7

L. Agrawal, W. Haq, C. Hanson, and D. Rao, Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity, J Immune Based Ther Vaccines, 2005.

K. Muthumani, M. Bagarazzi, D. Conway, D. Hwang, K. Manson et al., A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduce viral loads after pathogenic intrarectal SIVmac251 challenge in Rhesus Macaques, Vaccine, vol.21, issue.7-8, pp.629-666, 2003.
DOI : 10.1016/S0264-410X(02)00571-6

M. Gheradi, J. Ramirez, and E. M. , Interleukin-12 (IL-12) Enhancement of the Cellular Immune Response against Human Immunodeficiency Virus Type 1 Env Antigen in a DNA Prime/Vaccinia Virus Boost Vaccine Regimen Is Time and Dose Dependent: Suppressive Effects of IL-12 Boost Are Mediated by Nitric Oxide, Journal of Virology, vol.74, issue.14, pp.6278-86, 2000.
DOI : 10.1128/JVI.74.14.6278-6286.2000

K. Muthumani, S. Kudchodkar, D. Zhang, M. Bagarazzi, J. Kim et al., Issues for improving multi plasmid DNA vaccines for HIV-1. Vaccine, pp.1999-2003, 2002.

A. Moore, W. Kong, B. Chakrabarti, and G. Nabel, Effects of Antigen and Genetic Adjuvants on Immune Responses to Human Immunodeficiency Virus DNA Vaccines in Mice, Journal of Virology, vol.76, issue.1, pp.243-50, 2002.
DOI : 10.1128/JVI.76.1.243-250.2002

E. Schadeck, M. Sidhu, M. Egan, S. Chong, P. Piacente et al., A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques, Vaccine, vol.24, issue.21, pp.4677-87, 2006.
DOI : 10.1016/j.vaccine.2005.10.035

J. Stambas, S. Brown, A. Gutierrez, R. Sealy, W. Yue et al., Long lived multi-isotype anti-HIV antibody responses following a prime-double boost immunization strategy, Vaccine, vol.23, issue.19, pp.2454-64, 2005.
DOI : 10.1016/j.vaccine.2004.10.030

D. Barouch, N. Letvin, and R. Seder, The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses, Immunological Reviews, vol.13, issue.1, pp.266-74, 2004.
DOI : 10.1038/sj.gt.3301491

J. Williman, E. Lockhart, L. Slobbe, G. Buchan, and M. Baird, The use of Th1 cytokines, IL-12 and IL-23, to modulate the immune response raised to a DNA vaccine delivered by gene gun, Vaccine, vol.24, issue.21, pp.4471-4475, 2006.
DOI : 10.1016/j.vaccine.2005.08.011

S. Liljeqvist and S. Ståhl, Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines, Journal of Biotechnology, vol.73, issue.1, pp.1-33, 1999.
DOI : 10.1016/S0168-1656(99)00107-8

H. Jin, Y. Li, Z. Ma, F. Zhang, Q. Xie et al., Effect of chemical adjuvants on DNA vaccination, Vaccine, vol.22, issue.21-22, pp.2925-2960, 2004.
DOI : 10.1016/j.vaccine.2003.12.026